Zura Bio【ZURA】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.1697

買値

3.12

売値

3.93

出来高

391,789

3.145 日の範囲 3.72

2.00 52 週間の範囲 6.35

時価総額

206.961M

前日終値

3.60

始値

3.72

時刻

3.22

最終取引時間

財務取引量

US$ 1,314,880

VWAP

3.3561

平均取引量 (3 か月)

451,246

発行済株式数

65,293,530

配当利回り

PER

-2.99

1 株当たり利益 (EPS)

-1.06

歳入

純利益

-69.24M

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. 詳細を表示

セクター

Lab Analytical Instruments

業界

Blank Checks

ウェブサイト

zurabio.com

本社

Grand Cayman, Cym

設立

2023

Zura Bio Ltd is listed in the Lab Analytical Instruments sector of the ナスダック市場 with ticker ZURA. The last closing price for Zura Bio was US$3.60. Over the last year, Zura Bio shares have traded in a share price range of US$ 2.00 to US$ 6.35.

Zura Bio currently has 65,293,530 shares in issue. The market capitalisation of Zura Bio is US$235.06 million. Zura Bio has a price to earnings ratio (PE ratio) of -2.99.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.3803	-30.3362637363	4.55	4.85	3.1697	380326	4.21550464	CS
4	-1.7203	-35.1799591002	4.89	5.07	3.1697	336636	4.44856543	CS
12	-0.4203	-11.7075208914	3.59	5.07	3.1697	451246	4.24198461	CS
26	-2.0603	-39.3938814532	5.23	6.35	3.14	360155	4.09691082	CS
52	-1.1603	-26.7967667436	4.33	6.35	2	308131	3.86518352	CS
156	-4.8303	-60.37875	8	37.55	2	342800	6.56819806	CS
260	-4.8303	-60.37875	8	37.55	2	342800	6.56819806	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	US$ 0.44 (25.71%)	139.46M